Iodipamide Meglumine
This meglumine salt of iodipamide is an intravenous cholangiographic contrast medium used to visualize the biliary system on X-ray. After injection, it is excreted in bile, opacifying the bile ducts. Like other iodinated contrast agents, it carries a risk of allergic reactions and renal injury.
Peso Molecular
1530,2000 g/mol
TPSA
359,00 Ų
Mecanismo de Ação
Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.
Estrutura 2D
Cite this structure
Embed this structure
SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(CCCCC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I)Nc1c(I)cc(I)c(C(=O)O)c1I
InChI
InChI=1S/C20H14I6N2O6.2C7H17NO5/c21-7-5-9(23)17(15(25)13(7)19(31)32)27-11(29)3-1-2-4-12(30)28-18-10(24)6-8(22)14(16(18)26)20(33)34;2*1-8-2-4(10)6(12)7(13)5(11)3-9/h5-6H,1-4H2,(H,27,29)(H,28,30)(H,31,32)(H,33,34);2*4-13H,2-3H2,1H3/t;2*4-,5+,6+,7+/m.00/s1
Molecular Formula
C34H48I6N4O16
HBD / HBA
16 / 18
Ligações Rotacionáveis
21
Átomos Pesados
60
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
This meglumine salt of iodipamide is an intravenous cholangiographic contrast medium used to visualize the biliary system on X-ray. After injection, it is excreted in bile, opacifying the bile ducts. Like other iodinated contrast agents, it carries a risk of allergic reactions and renal injury.
Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.
Yes, Iodipamide Meglumine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989806. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 636408. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="iodipamide-meglumine"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/iodipamide-meglumine/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/iodipamide-meglumine/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/iodipamide-meglumine/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="iodipamide-meglumine"></drugfyi-drug>